Drug is used to eliminate residual tumor cells and to reduce the frequency of tumor recurrence.
At the end of 2 h, patient should void in a seated position for safety reasons. If there is an increase in patient's existing symptoms, if symptoms persist, or if any symptoms develop, evaluate patient and manage for urinary tract infection or BCG toxicity. Contraindicated in patients on immunosuppressive therapy or with compromised immune systems. Consider possibility of allergic reactions in sensitive individuals. Systemic side effects may represent hypersensitivity reactions and can be treated with diphenhydramine.